๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Evaluation of single-tube osmotic fragility as a screening test for thalassemia

โœ Scribed by Jason Chow; Lorraine Phelan; Barbara J. Bain


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
59 KB
Volume
79
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Evaluation of DNA flow cytometry as a sc
โœ Ralph W. Devere White; Arline D. Deltch ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 531 KB

At this present time, we feel that there is no role for DNA flow cytometry (FCM), or indeed DNA studies by any other method, to be used as a screening procedure for patients with no prior history of bladder cancer due to the high false-positive rate found when monitoring exfoliated urothelial cells.

Evaluation of Fasting Plasma Glucose as
โœ Lee, C.H.; Fook-Chong, S. ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 131 KB ๐Ÿ‘ 1 views

To assess the performance of different cutoff points for fasting plasma glucose (FPG) including the World Health Organization (WHO) cutoff of FPG ัƒ7.8 mmol l -1 for the screening of diabetes mellitus, data from oral glucose tolerance tests done on 865 Singaporean adults over a 4-year period were ana

Validity of analysis of FMRP expression
โœ M. Shyla Ravindran; Zareen M. Patel; Rashmi A. Adhia; Aruna K. D'souza; Shiny Ba ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 86 KB

## Abstract Molecular diagnosis of Fragile X Syndrome (FXS) is carried out by PCR or Southern blot analysis on DNA isolated from leukocytes. These DNA analyses are time consuming and expensive, making it impractical for mass screening programs. We have recently standardized and tested the diagnosti